ENTITY
InnoCare Pharma

InnoCare Pharma (9969 HK)

120
Analysis
Health Care • China
InnoCare Pharma is a commercial-stage biopharmaceutical company dedicated to discovering, developing, and commercializing drugs for cancer and autoimmune diseases. Its pipeline includes key products like orelabrutinib, tafasitamab, and ICP-332. The company was co-founded in 2015 and is headquartered in Beijing, China.
more
Exchange Announcement • 12 Oct 2026 16:38

Date Of Board Meeting

Exchange Announcement • 24 Sep 2026 12:05

Inside Information Announcement - Strategic Research Collaboration And License Agreement With Eli Lilly And Company

Exchange Announcement • 22 Sep 2026 16:35

Interim Report 2026

Exchange Announcement • 17 Sep 2026 16:59

Next Day Disclosure Return - Changes In Issued Share Capital

Exchange Announcement • 24 Aug 2026 17:31

Interim Results Announcement For The Six Months Ended 30 June 2026

x